Adam M. Kruszewski, MD
Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
View 1 additional location
Penn Medicine Provider

About me

Education and training

  • Medical School: University of Maryland School of Medicine
  • Residency: Temple University Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

695 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
he is one of the best doctors
November 2025
friendly and thorough.
October 2025
best doctor
October 2025
always answer my questions

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kruszewski is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Tomlinson SB, Rahmani R, Jabarkheel R, Kruszewski AM, Yoshor D, Srinivasan VM Resolution of Symptomatic Intracranial Hypertension Following Resection of Tentorial Meningioma Compressing the Dominant Transverse Sinus , J Neurol Surg Rep, 86: 2025,e170-e174


Liu T, Chebolu AP, Chung CW, Kruszewski AM, Bhatt N, Brucker AJ Bilateral uveitis, retinal periphlebitis, and optic neuritis associated with non-pineal central nervous system germinoma , Retin Cases Brief Rep, 19: 2025,182-186


Kruszewski AM, Tamhankar MA. Ophthalmic Manifestations of Giant Cell Arteritis , Int Ophthalmol Clin, 63: 2023,13-23


Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Cimino ME, Khella SL, Lancaster E, Bird SJ, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA. Vision Loss as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy: A Case Series , J Neuroophthalmol, 43: 2023,48-54


Kruszewski AM, Reid JE, Malik A, Maris JM, Liu GT. Mydriasis as a side effect of dinutuximab immunotherapy in pediatric neuroblastoma: a case series. , North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX.: 2022


Kruszewski AM, White BF, Ying GS, Fisher MJ, Storm PB, Avery RA, Liu GT. Visual acuity outcomes after open versus endoscopic endonasal surgery for pediatric craniopharyngioma. , North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX.: 2022


Jurkute N, Bertacchi M, Arno G, Tocco C, Kim US, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn SJ, Pontikos N, Acheson J, Davagnanam I, Bowman R, Kaliakatsos M, Gardham A, Wakeling E, Oluonye N, Reddy MA, Clark E, Rosser E, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson AG, Holder GE, Jeanjean L, Martinez-Monseny A, Vidal-Santacana M, Dominici C, Gaggioli C, Giordano N, Caleo M, Liu GT; Genomics England Research Consortium; Webster AR, Studer M, Yu-Wai-Man P. Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model , Brain Commun, 3: 2021,fcab162


Jurkute N, Bertacchi M, Arno G, Tocco C, Kim U, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn S, Acheson J, Davagnanam I, Bowman R, Kaliakatsos, M, Reddy A, Oluonye N, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson A, Holder G, Jeanjean L, Martinez-Monseny A, Liu GT, Webster A, Studer M, Yu-Wai-Man P. Pathogenic NR2F1 variants cause a systemic neurodevelopmental ocular phenotype recapitulated in a mutant mouse model. , North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting.: 2021


Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Khella SL, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA. Vision Loss In Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Series. , North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting. : 2021


Tatomir A, Talpos-Caia A, Anselmo F, Kruszewski AM, Boodhoo D, Rus V, Rus H. The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis , Immunol Res: 2017